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In order to allocate rationally resources for research and surveillance 
of infectious diseases at the level of the German public health 
institute (RKI), we prioritised pathogens by public health criteria. 
After screening the relevant literature we developed a standardised 
methodology including a three-tiered scoring system for selected 
pathogens. The pathogens were rated in four categories containing a 
total of 12 criteria: burden of disease including incidence, severity, 
mortality; epidemiologic dynamic including outbreak potential, 
trend, emerging potential; information need including evidence on 
risk factors/groups, validity of epidemiologic information, evidence 
for pathogenesis; international duties and public attention; health 
gain opportunity including preventability, treatability. For each 
criterion a numerical score of +1, 0 or -1 was given and each 
criterion received a weight by which the numerical score of each 
criterion was to be multiplied.  The total weighted scores ranged 
from +22.7 (influenza) to - 64.4 (cholera) with the median 
being -22.9 (rubella). Relevant changes were observed between 
weighted and unweighted scores. The chosen approach proved to 
be feasible and the result plausible. However, in order to further 
improve the methodology we invite experts to give feedback on the 
methodology via a structured web-based questionnaire at www.rki.
de/EN > Prevention of infection > Infectious Disease Surveillance 
> Pathogen prioritization. Results of this survey will be included 
in a modification of the methodology.
Background
One of the challenges of public health is that infectious disease 
control covers a wide range of pathogens requiring diverse methods 
for prevention and control. Furthermore, infectious diseases vary 
greatly in occurrence, severity and other factors that make it 
difficult to compare the public health importance of the underlying 
pathogens. Resources for research, surveillance and other public 
health activities are limited; it is therefore of major importance 
to allocate rationally these resources by using public health 
criteria. The agendas of institutions in the field of public health 
and infectious diseases, however, are fragmented and experts are 
increasingly specialised, making it difficult to find institutions 
or individuals who would be able to prioritise a broad range of 
infectious diseases without being biased by individual professional 
focus on one hand or lack of specific pathogen-related knowledge 
on the other. 
In the past decade a number of efforts have been made to 
prioritise systematically infectious diseases by public health criteria 
resulting in different outcomes depending on the objectives and 
methodology used [1-5]. But even prioritisation schemes with 
similar objectives have applied different sets of criteria as illustrated 
in Table 1.
In 2004 the department for infectious disease epidemiology of 
the Robert Koch Institute (RKI), the national public health institute 
in the portfolio of the German federal ministry of health, initiated 
a prioritisation exercise to guide the research and surveillance 
strategies of the department [6]. Initial findings were presented 
at three international scientific conferences in 2006 and 2007 
[7-9].
After this a publication in a nationwide non-scientific journal 
[10] elicited considerable and unexpected interest from the general 
public and the scientific community. Therefore, as part of updating 
and improving the current prioritisation methodology, we would 
like to present this methodology also to the broader international 
public health community outside the RKI and Germany to collect 
suggestions for improvement. In the following we describe and 
evaluate the methodology of the prioritisation previously conducted 
by the RKI to provide the background information necessary for 
comment on our approach. We cordially invite comments on the 
proposed methodology via a web-based questionnaire accessible at 
http://www.rki.de/EN > Prevention of infection > Infectious Disease 
Surveillance > Pathogen prioritization. 
Methodology
While preparing our exercise we analysed prioritisation efforts 
over the past decade by searching the literature in Medline using 
the search terms prioritisation OR priority AND (surveillance OR 
infectious diseases OR public health) and based on presentations 
from the EAN workshop on “New Tools for early Warning” that took 
place in Lyon on 6 and 7 February 2004, [1-5,18,19]. A flow chart 
of our methodology is presented in Figure 1. 
A list of pathogens was compiled based on one or more of 
the following criteria: notifiable according to German law [11], 
reportable within the European Union according to European 
regulations [12], listed as chapters in selected established manuals 
and textbooks on infectious diseases [13-15], causative agent in 
outbreaks reported to RKI in the past 10 years, agent with potential 
for deliberate release [16]. In the following we list the pathogens 
but also refer to the related diseases in humans.
Every pathogen was rated according to the 12 criteria listed in 
Table 2. For each criterion a numerical score of +1, 0 or -1 was 
given as defined in Table 2. The score of +1 represented high and 
a score of -1 low importance with respect to a criterion. A score 
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T a b l e  1
Comparison of the evaluation criteria of different schemes for prioritisation of infectious diseases (the prioritisation by Reseau National de 
Santé Publique, 1995, France, is not included as it contained categorisation principles rather than criteria) between 1995 and 2008
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of 0 referred to pathogens with average importance or pathogens, 
for which lack of knowledge or opinion of the participants in the 
working group did not allow a decision for one of the other two 
scores.
Each criterion received a weight by which the numerical score 
of each criterion was to be multiplied. Hence for each pathogen 
a sum of the unweighted and a sum of the weighted scores was 
generated. The weight of each criterion was determined before 
and independently of the categorisation for each pathogen: all 
participants were asked to put the 12 criteria in a sequential order 
with 12 being the most important and one being the least important 
criterion. An average was computed for each criterion, defining its 
weight. The total weighted score was defined as the sum of the 
weighted scores of all 12 categories per pathogen. These were 
finally normalised to the spectrum of the unweighted total scores 
to allow comparisons. We demonstrate the effect of weighting by 
presenting detailed data on the highest, lowest and median ranking 
pathogen as well as for the two pathogens with adjacent ranks to 
the median rank.
Results
The overview of prioritisation exercises in Table 3 shows that 
objectives, methodological approaches and especially the level of 
standardisation differed considerably in these efforts. Partly due to 
different objectives of the prioritisation, also the number and type 
of criteria varied. Categories used by most groups are incidence, 
burden of disease and opportunity for health gain [1-5], which are 
included in our exercise.
The working group on prioritisation consisted of eleven senior 
epidemiologists and infectious disease specialists at the department 
for infectious disease epidemiology at RKI. They categorised a list 
of 85 pathogens shown in Table 4.
The distribution of the normalised ranks is presented in Figure 
2 and detailed scores for selected diseases are shown in Table 5. 
The total weighted scores ranged from +22.7 (influenza) to - 64.4 
(cholera) with the median being -22.9 (rubella). The spectrum 
found in the total unweighted scores contained 12 possible ranks 
ranging from +2 to -9. Table 5 demonstrates the differences 
obtained from weighting for some selected pathogens.
T a b l e  2




Incidence <1/100.000 1/100.000-20/100.000 >20/100.000
Severity 
hospitalisation is very rare, work 
loss less than 2 days, no persisting 
handicaps
hospitalisation is rare, work loss of 
more than 5 days is rare, very rarely 
persisting handicaps
hospitalisation is frequent, work 
loss of more than 5 days is frequent, 
persisting handicaps do occur
Mortality* <50 deaths/year in Germany between 50 und 500 deaths /year in Germany
more than 500 deaths /year in 
Germany
Epidemiologic dynamic 
Outbreak potential outbreaks are very rare outbreaks with 5 or more cases are rare
outbreaks with 5 or more cases are 
frequent
Trend diminishing incidence rates stable incidence rates increasing incidence rates
Emerging potential disease already endemic or very unlikely to be introduced to Germany
disease has the potential to be 
introduced to Germany sporadically 
disease is likely to emerge in Germany 
in a relevant way
Information need
Evidence for risk factors /groups risk factors and risk groups are identified based on scientific evidence
risk factors and risk groups are 
basically known but scientific 
evidence is missing
risk factors and risk groups are not 
known
Validity of epidemiologic information epidemiologic situation is well known and scientifically valid
epidemiologic information exists but 
is scientifically not very valid
epidemiologic information is 
insufficient
International duties and public 
attention
no international duties or political 
agenda, minor public attention
no international duties but informal 
political expectations, moderate public 
attention
international duties or explicit 
political agendas, high public 
attention
Evidence for pathogenesis 
information on pathogenesis and 
transmission routes is  available and 
well supported by scientific evidence
information on pathogenesis and 
transmission routes is  basically 
available but not well supported by 
scientific evidence
information on pathogenesis and 




there are hardly any possibilities for 
prevention or there is no need for 
prevention
concepts for prevention are 
established but there is need for 
further research to improve its 
effectiveness
strong need for further research on 
preventive measures because need for 
prevention is clear but concepts for 
prevention are missing 
Treatability
medical treatment is rarely necessary 
or effective treatments are available 
to positively influence the burden of 
disease or the prognosis
medical treatment is frequently 
indicated but medical  treatments 
only have a limited  influence on the 
burden of disease or the prognosis
medical treatment is desirable but 
currently there is no treatment 
available that  positively influences 
the burden of disease or the 
prognosis
Proposed alternative to mortality
Case fatality rate* <0,01% 0,01- 1% > 1% 
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T a b l e  3
Distribution of pathogens by total weighted and un-weighted scores during prioritisation, Robert Koch Institute, 2008  
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T a b l e  4
List of pathogens selected for prioritisation, Robert Koch Institute, 2008
Adenovirus Escherischia  coli, shigella toxin producing (STEC/HUS) Leishmania spp. Salmonella typhi
Babesia microti Echinococcus granulosus Leptospira interrogans Shigella spp.
Bacillus anthracis Echinococcus multilocularis Listeria monocytogenes Staphylococcus aureus, methicillin resistant (MRSA)
Bartonella spp. Ehrlichia chaffeensis Measles virus Staphylococcus aureus, toxigenic
Bordetella pertussis Entamoeba histolytica Microsporum spp. Streptococcus spp. other than Str.pneumoniae
Borrelia burgdorferi Epstein-Barr virus Molluscipoxvirus Streptococcus pneumoniae
Brucella abortus Francisella tularensis Mumps virus Toxoplasma gondii
Bovine Spongioform Encephalitis (BSE)/ 
variant Creutzfeldt Jakob Disease 
(vCJD)
Giardia lamblia Mycobacterium Leprae Treponema pallidum
Campylobacter jejuni Haemophilus influenzae Mycobacterium tuberculosis Trichinella spiralis
Central European tickborne 
encephalitis virus Hanta virus
Mycobacterium, other (non-
tuberculous) Trichomonias vaginalis
Chlamydophila pneumoniae Helicobacter pylori Mycoplasma spp. Varicella virus
Chlamydophila psittaci Hepatitis A virus Neisseria gonorrhoeae Variola virus
Chlamydia trachomatis Hepatitis B virus Neisseria meningitidis Vibrio cholerae
Clostridium botulinum Hepatitis C virus Norovirus Viruses, others causing hemorrhagic fevers
Clostridium tetani Hepatitis D virus Parvovirus B 19 West Nile virus
Corynebacterium diphtheria Hepatitis E virus Plasmodium spp. Yellow fever virus
Coxiella burnetii Herpes simplex virus (HSV) Polio virus Yersinia enterocolitica
Cryptosporidium parvum Human immunodeficiency virus (HIV) Rabiesvirus Yersinia pestis
Cyclospora cayetanensis Human papilloma virus (HPV) Rota virus Yersinia pseudotuberculosis
Cytomegalovirus Human T-cell lymphotrophic virus (HTLV) Rubellavirus  
Dengue virus Influenza virus Salmonella spp. (non typhi non paratyphi)  
Escherischia coli, enteropathogenic 
(non STEC/HUS) Legionella pneumophila Salmonella paratyphy  
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Discussion and conclusions
The described methodology builds on the experiences of 
similar efforts [1-5,18, 19] and attempts to increase the level of 
standardisation and transparency in prioritising pathogens based 
on public health criteria. In comparison to the cited prioritisation 
efforts, our approach may appear overly standardised. We believe, 
however, this ensures transparency and reproducibility, which are 
important, especially as prioritisation may easily affect funding and 
policy issues. Furthermore, our methodology allows for adaptations 
if certain conditions change e.g. if a vaccine becomes available or 
if the incidence changes significantly. 
The result of the prioritisation at RKI shows a multi-modal 
distribution with the majority of scores below 0 indicating that, 
with a given definition of scores and a list of diseases to prioritise, 
participants tended to opt more frequently for lower scores. 
Therefore, we propose to replace the criterion of mortality by case 
fatality, as presented in Table 2, because mortality is implicitly 
dependant on incidence, whereas case fatality is another criterion 
for burden of disease complementing the criterion of severity. 
Among the selected diseases presented, the proposed exchange 
would somewhat lower the score for influenza but it does not seem 
to result in a relevant change of ranking. 
A five-tiered scoring system as used in the overview of 
communicable diseases or in the Dubrovnik pledge could allow 
for a more differentiated scoring than the three-tiered system we 
used  [2-4]. However, the challenge to generate clear definitions for 
each score increases with the number of scores. For many diseases 
and criteria information may not be available in the detail needed 
to permit such a differentiated approach. 
The examples in Table 5 demonstrate that some diseases that 
were far apart in the unweighted scaling moved close together after 
weighting had been applied. This makes it obvious that weighting 
is important and that it may result in changes in both directions. 
There is reason to believe that the objectiveness of the procedure 
is increased if weighting is done independently of, and prior to, 
T a b l e  5
Prioritisation scores for five selected pathogens out of 85, Robert Koch Institute, 2008
Crude weighted scores
Maximum Median Minimum
Disease Weight Influenza Rotavirus Rubella Cyclosporiasis Cholera
Burden of disease
Incidence 10.7 10.7 10.7 0 -10.7 -10.7 
Severity 10.3 0 -10.3 -10.3 -10.3 0
Mortality 8.4 8.4 0 -8.4 -8.4 -8.4
Epidemiologic dynamic
Outbreak potential 10.1 10.1 10.1 10.1 0 -10.1
Epidemiologic trend 7.7 0 0 0 0 -7.7
Emerging potential 5.4 -5.4 -5.4 -5.4 0 0
Information need
Evidence for risk factors /groups 5.5 -5.5 -5.5 -5.5 5.5 -5.5
Validity of epidemiologic 
information 5.4 -5.4 -5.4 0 5.4 -5.4
Political agendas, public awareness 5.2 5.2 0 -5.2 -5.2 0
Evidence for pathogenesis 3.4 -3.4 -3.4 -3.4 0 -3.4
Health gain opportunity
Preventability 8.0 8 -8 0 0 -8
Treatability 5.2 0 -5.2 5.2 0 -5.2
Total weighted score (crude) 22.7  -22.8 -22.9 -23.7 -64.4
Total unweighted score 1 -5 -4 -2 -9
Total weighted score (normalised to a scale from +2 
to -9) 2 -4 -4 -4 -9
F i g u r e  2
Distribution of pathogens by total weighted and unweighted scores 
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scoring. This is a way to avoid individual preferences of participants 
biasing the process. The advantage of quantitatively determining 
the weight for each individual criterion is that other institutions 
may choose to apply different weights to adapt the ranking to their 
respective mission. This increases the flexibility of the system and 
allows it to be used for different applications. For example the 
Eurostat task force on human health issues related to food safety 
has recently adopted a number of our criteria and also our concept 
of weighting in an attempt to identify the top 20 diseases from the 
inventory of food safety related diseases in Europe. (Ana Martinez, 
Eurostat, personal communication) 
Call for comments
For an upcoming update of our prioritisation methodology we 
plan to include the views from experts from various fields and 
institutions outside the RKI. 
While suggesting that a structured prioritisation approach similar 
to the one presented here is useful, there are still a number of 
questions that we plan to re-assess before going through such a 
procedure again:
• Does the list contain all relevant pathogens? 
• Do the 12 criteria cover the relevant characteristics for 
prioritisation and are they not redundant or strongly dependant 
on each other? If other categories are missing, would the 
available information suffice to allow scoring based on defined 
scores? 
• For which categories would a five-tiered scaling be a major 
improvement and if so would it be feasible to generate clear 
definitions for each scale? 
• Are the existing definitions for the three scores for each criterion 
clear and plausible? Can they be applied? Are they valid to 
detect differences? 
• Is the weighting of the criteria plausible? 
• How large should the group of participating experts be and how 
should it be composed? 
We invite suggestions, feedback and answers to the questions 
above through a structured web-based questionnaire available from 
http://www.rki.de/EN > Prevention of infection > Infectious Disease 
Surveillance > Pathogen prioritization. This may initiate a fruitful 
discussion in the scientific community and provide some guidance 
on how to improve our prioritisation scheme and maybe that of 
other institutions. Ultimately, we hope this will in return contribute 
to rational allocation of attention and resources in the control and 
prevention of infectious diseases.
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